CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
40.72
+0.34 (0.83%)
At close: Dec 20, 2024, 4:00 PM
40.95
+0.23 (0.56%)
After-hours: Dec 20, 2024, 7:32 PM EST
CRISPR Therapeutics AG Operating Expense Breakdown
History
| Date | Research and Development | Collaboration | General and Administrative |
|---|---|---|---|
| Jun 30, 2024 | 342.18M | 142.52M | 72.20M |
| Mar 31, 2024 | 363.57M | 135.02M | 71.76M |
| Dec 31, 2023 | 387.33M | 130.25M | 76.16M |
| Sep 30, 2023 | 395.74M | 117.07M | 80.85M |
| Jun 30, 2023 | 421.67M | 132.51M | 89.56M |
| Mar 31, 2023 | 443.34M | 121.80M | 96.80M |
| Dec 31, 2022 | 461.65M | 110.25M | 102.46M |
| Sep 30, 2022 | 461.19M | 135.25M | 104.97M |
| Jun 30, 2022 | 428.06M | 118.86M | 101.68M |
| Mar 31, 2022 | 387.17M | 111.88M | 104.21M |
| Dec 31, 2021 | 339.55M | 101.18M | 100.71M |
| Sep 30, 2021 | 318.82M | 69.35M | 102.80M |
| Jun 30, 2021 | 306.33M | 46.89M | 100.63M |
| Mar 31, 2021 | 283.37M | 19.95M | 93.18M |
| Dec 31, 2020 | 266.95M | - | 88.21M |
| Sep 30, 2020 | 233.34M | - | 79.71M |
| Jun 30, 2020 | 219.58M | - | 73.69M |
| Mar 31, 2020 | 199.73M | - | 68.11M |
| Dec 31, 2019 | 179.36M | - | 63.49M |
| Sep 30, 2019 | 159.40M | - | 62.76M |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.